Literature DB >> 11515789

Coronaviruses in brain tissue from patients with multiple sclerosis.

R B Dessau1, G Lisby, J L Frederiksen.   

Abstract

Brain tissue from 25 patients with clinically definite multiple sclerosis (MS) and as controls brain tissue from 36 patients without neurological disease was tested for the presence of human coronaviral RNA. Four PCR assays with primers specific for N-protein of human coronavirus strain 229E and three PCR assays with primers specific for the nucleocapsid protein of human coronavirus strain OC43 were performed. Sporadic positive PCR assays were observed in both patients and controls in some of the PCR assays. However, these results were not reproducible and there was no difference in the proportion of positive signals from the MS patients compared to controls. Evidence for a chronic infection with the human coronaviruses strain 229E or OC43 in brain tissue from patients with MS or controls has not been found in this study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11515789      PMCID: PMC7086566          DOI: 10.1007/s004010000331

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event.

Authors:  Leen Vijgen; Els Keyaerts; Elien Moës; Inge Thoelen; Elke Wollants; Philippe Lemey; Anne-Mieke Vandamme; Marc Van Ranst
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  The role of infections in the pathogenesis and course of multiple sclerosis.

Authors:  Siddharama Pawate; Subramaniam Sriram
Journal:  Ann Indian Acad Neurol       Date:  2010-04       Impact factor: 1.383

3.  Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts.

Authors:  Olaoluwa Okusaga; Robert H Yolken; Patricia Langenberg; Manana Lapidus; Timothy A Arling; Faith B Dickerson; Debra A Scrandis; Emily Severance; Johanna A Cabassa; Theodora Balis; Teodor T Postolache
Journal:  J Affect Disord       Date:  2010-10-27       Impact factor: 4.839

Review 4.  Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses.

Authors:  Peter Riederer; Volker Ter Meulen
Journal:  J Neural Transm (Vienna)       Date:  2020-07-28       Impact factor: 3.575

Review 5.  Vaccination in Multiple Sclerosis: Friend or Foe?

Authors:  Tobias Zrzavy; Herwig Kollaritsch; Paulus S Rommer; Nina Boxberger; Micha Loebermann; Isabella Wimmer; Alexander Winkelmann; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

6.  Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms.

Authors:  Emily G Severance; Faith B Dickerson; Raphael P Viscidi; Ioannis Bossis; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken
Journal:  Schizophr Bull       Date:  2009-06-02       Impact factor: 9.306

Review 7.  COVID-19: dealing with a potential risk factor for chronic neurological disorders.

Authors:  Tommaso Schirinzi; Doriana Landi; Claudio Liguori
Journal:  J Neurol       Date:  2020-08-27       Impact factor: 4.849

Review 8.  Lifting the mask on neurological manifestations of COVID-19.

Authors:  Alessandro Pezzini; Alessandro Padovani
Journal:  Nat Rev Neurol       Date:  2020-08-24       Impact factor: 42.937

Review 9.  Should we expect neurological symptoms in the SARS-CoV-2 epidemic?

Authors:  J Matías-Guiu; U Gomez-Pinedo; P Montero-Escribano; P Gomez-Iglesias; J Porta-Etessam; J A Matias-Guiu
Journal:  Neurologia (Engl Ed)       Date:  2020-04-06

Review 10.  Coronaviruses and the central nervous system.

Authors:  Susan Morgello
Journal:  J Neurovirol       Date:  2020-07-31       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.